Form 8-K - Current report:
SEC Accession No. 0001140361-24-045461
Filing Date
2024-11-07
Accepted
2024-11-06 21:11:21
Documents
15
Period of Report
2024-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20038150x1_8k.htm   iXBRL 8-K 61326
2 EXHIBIT 2.1 ny20038150x1_ex2-1.htm EX-2.1 614893
3 EXHIBIT 99.1 ny20038150x1_ex99-1.htm EX-99.1 23207
  Complete submission text file 0001140361-24-045461.txt   994087

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cdmo-20241106.xsd EX-101.SCH 3979
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdmo-20241106_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdmo-20241106_pre.xml EX-101.PRE 16042
18 EXTRACTED XBRL INSTANCE DOCUMENT ny20038150x1_8k_htm.xml XML 4058
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 241432786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)